Healthcare stocks are mostly lower, with the NYSE Healthcare
Sector Index falling 0.6% and shares of healthcare companies in the
S&P 500 giving up 0.7% as a group.
In company news, AtriCure Inc. (
) is enjoying a big run higher, with shares of the atrial
fibrillator climbing 11.7% to $13.90 each after posting a $0.13 per
share Q3 net loss, in from a $0.16 per share loss in the year-ago
period and also besting analyst expectations by $0.03 per
Quarterly revenue rose 24.8% from the same quarter last year to
$20.15 million, exceeding the Thomson Reuters consensus by $1.84
million, or over 10%.
Looking forward, ATRC management now sees FY13 revenue rising
14% over the prior fiscal year to $80 million, up from its previous
guidance looking for an increase of between 10% to 12% over FY12.
The Street is at $78.26 million.
In other sector news,
(+) NUVA, (+20.7%) Q3 EPS of $0.39 beats by $0.15. Revenue
climbs 14.0% to $169.2 mln, topping the consensus view by $10.76
mln. Raises FY13 EPS guidance by $0.14 to $1.14 per share, boosts
revenue forecast by $15 mln to $670 mln, both topping consensus
(-) PRXL, (-15.5%) Q1 GAAP earnings of $0.45 per share match
estimates by $449.2 mln in revenue misses by $7.11 mln. Projected
Q2 earnings match consenus while revenue is seen exceeding Street
view by $2.21 mln. Issues in-line FY14 earnings, revenue
Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.